Skip to main content

Table 5 OM incidence rate in the experimental and control groups within the prevention group

From: A prospective interventional study of recombinant human interleukin-11 mouthwash in chemotherapy-induced oral mucositis

Prevention

No. of patients

Classification of oral mucositis

Incidence rate

0

I

II

III

IV

Experimental group

34

30(88.2%)

3(8.8%)

1(3%)

0(0%)

0(0%)

11.8%

Control group

28

21(75%)

4(14.3%)

2(7.1%)

1(3.6%)

0(0%)

25.0%

P value

 

p = 0.16 (the wilcoxon test was adopted)

p = 0.175